SCHEMBL17595307

SCHEMBL17595307

COC(=O)C1C=COC(O)C1=O

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.30
HIF1A Q16665 1/20 0.30
FUCA1 P04066 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304987 0.73 FUCA1 (0.31) FUCA1
SCHEMBL15583 0.69
SCHEMBL27694745 0.61
SCHEMBL7929530 0.60 DNTT (0.37) CYP1A2
SCHEMBL10682082 0.60 ALDH1A1 (0.35) CYP1A2HIF1A
Tetrahydrofuran SCHEMBL8329821 0.60 FUCA1 (0.33) FUCA1
SCHEMBL16379058 0.59 ALDH1A1 (0.33) FUCA1
Iodide SCHEMBL11560630 0.59
SCHEMBL11981195 0.59 ALDH1A1 (0.33) FUCA1
SCHEMBL11964012 0.59 NPSR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968176-B2 Pyrrolidone derivatives, oligomers and polymers NANOSYNTHONS LLC (US) 2021-04-06 US disclosed
US-20190352258-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS NANOSYNTHONS LLC (US) 2019-11-21 US disclosed
US-10420849-B2 Pyrrolidone derivatives, oligomers and polymers NANOSYNTHONS LLC (US) 2019-09-24 US disclosed
US-20170246323-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS NANOSYNTHONS LLC (US) 2017-08-31 US disclosed
EP-3194365-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS Nanosynthons LLC (US) 2017-07-26 EP disclosed
WO-2016040962-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS NANOSYNTHONS LLC (US) 2016-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968176-B2 Pyrrolidone derivatives, oligomers and polymers POF1B, VGF, RAB5IF CYP1A2 1779/4885HIF1A 4354/4885FUCA1 3652/4885
US-20190352258-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS POF1B, VGF, RAB5IF CYP1A2 1779/4885HIF1A 4354/4885FUCA1 3652/4885
US-20170246323-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS POF1B, VGF, RAB5IF CYP1A2 1800/4885HIF1A 4360/4885FUCA1 3627/4885
US-10420849-B2 Pyrrolidone derivatives, oligomers and polymers POF1B, VGF, RAB5IF CYP1A2 1800/4885HIF1A 4360/4885FUCA1 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.